Andrew Lee, Catherine Go, Frank Annie, Ryan Butcher, Mohammad H Eslami
{"title":"Vein Harvest Technique Is Not Associated with Major Adverse Limb Events.","authors":"Andrew Lee, Catherine Go, Frank Annie, Ryan Butcher, Mohammad H Eslami","doi":"10.1016/j.jvs.2025.07.024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Benefits of vein conduits in lower extremity bypasses (LEB) are known but there is debate about the harvesting technique. We aimed to compare the impact of conduit harvest on major adverse limb event (MALE) and MALE-free survival (MFS).</p><p><strong>Methods: </strong>We conducted a retrospective review of LEB patients with vein from 2013-2022 at our single-center institution. Patients were divided into groups: EVH (n=80) and OVH (n=204). The primary endpoints were MALE and MFS, while secondary endpoints included 30-day infection rate (IR), operative time, discharge status, post-operative length-of-stay (LOS), and estimated blood loss (EBL). MALE and MFS were compared using log ranks and Kaplan-Meier analysis. Adjusted analyses to determine factors associated with MALE and MFS at 1-, and 3-years were performed.</p><p><strong>Results: </strong>At 1- and 3-years, MALE and MFS were not statistically different. At 1-year, EVH MALE was 35% vs. 37% for OVH (p=0.871), and 61% vs. 55% (p=0.434) at 3-years. At 1-year, EVH MFS was 63% vs. 65% for OVH (p=0.434), and 39% vs. 45% (p=0.44) at 3-years. There were no significant differences in 30-day IR (1.25% vs. 3.88%; p=0.30), EBL (397.31 ± 336.00 vs. 479.57 ± 493.81 mL; p=0.12), discharge home vs. other facility (88.61% vs. 85.92%; p=0.63), and LOS (7.09 ± 4.98 vs. 7.92 ± 6.24 days; p=0.30). On adjusted analyses, harvest technique was not associated with MALE or MFS at 1- and 3-years. Adjusted analyses revealed no association between vein harvest technique and MALE at 1-year. It did show significant differences in MALE at 1-year for bypasses whose proximal anastomoses originated in the below-knee popliteal and tibial artery segments (HR, 2.50; 95% CI, 1.30-4.80; p=0.01) and bypasses that consisted of 2 or more vein segments (HR, 1.86; 95% CI, 1.25-2.76; p<0.01); both findings were still significant at 3-years and neither were associated with vein harvest technique. There were no co-morbidities that affected MALE at 1-year, but patients with MALE at 3-years were associated with COPD (HR, 1.46; 95% CI, 1.08-1.99; p=0.02) and diabetes (HR, 1.51; 95% CI, 1.12-2.03; p=0.01). There were no variables associated with a return to the operating room except for female sex (OR, 2.317; 95% CI, 1.214-4.424; p=0.011). There was still no difference in 30-day IR even after adjusted analysis.</p><p><strong>Conclusion: </strong>Although EVH is not associated with improved infection rates and LOS, this technique does not affect MALE or MFS compared to OVH. Economic impact and patient satisfaction of EVH require further studies to define the role of less invasive approaches to vein harvest.</p>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jvs.2025.07.024","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Benefits of vein conduits in lower extremity bypasses (LEB) are known but there is debate about the harvesting technique. We aimed to compare the impact of conduit harvest on major adverse limb event (MALE) and MALE-free survival (MFS).
Methods: We conducted a retrospective review of LEB patients with vein from 2013-2022 at our single-center institution. Patients were divided into groups: EVH (n=80) and OVH (n=204). The primary endpoints were MALE and MFS, while secondary endpoints included 30-day infection rate (IR), operative time, discharge status, post-operative length-of-stay (LOS), and estimated blood loss (EBL). MALE and MFS were compared using log ranks and Kaplan-Meier analysis. Adjusted analyses to determine factors associated with MALE and MFS at 1-, and 3-years were performed.
Results: At 1- and 3-years, MALE and MFS were not statistically different. At 1-year, EVH MALE was 35% vs. 37% for OVH (p=0.871), and 61% vs. 55% (p=0.434) at 3-years. At 1-year, EVH MFS was 63% vs. 65% for OVH (p=0.434), and 39% vs. 45% (p=0.44) at 3-years. There were no significant differences in 30-day IR (1.25% vs. 3.88%; p=0.30), EBL (397.31 ± 336.00 vs. 479.57 ± 493.81 mL; p=0.12), discharge home vs. other facility (88.61% vs. 85.92%; p=0.63), and LOS (7.09 ± 4.98 vs. 7.92 ± 6.24 days; p=0.30). On adjusted analyses, harvest technique was not associated with MALE or MFS at 1- and 3-years. Adjusted analyses revealed no association between vein harvest technique and MALE at 1-year. It did show significant differences in MALE at 1-year for bypasses whose proximal anastomoses originated in the below-knee popliteal and tibial artery segments (HR, 2.50; 95% CI, 1.30-4.80; p=0.01) and bypasses that consisted of 2 or more vein segments (HR, 1.86; 95% CI, 1.25-2.76; p<0.01); both findings were still significant at 3-years and neither were associated with vein harvest technique. There were no co-morbidities that affected MALE at 1-year, but patients with MALE at 3-years were associated with COPD (HR, 1.46; 95% CI, 1.08-1.99; p=0.02) and diabetes (HR, 1.51; 95% CI, 1.12-2.03; p=0.01). There were no variables associated with a return to the operating room except for female sex (OR, 2.317; 95% CI, 1.214-4.424; p=0.011). There was still no difference in 30-day IR even after adjusted analysis.
Conclusion: Although EVH is not associated with improved infection rates and LOS, this technique does not affect MALE or MFS compared to OVH. Economic impact and patient satisfaction of EVH require further studies to define the role of less invasive approaches to vein harvest.
期刊介绍:
Journal of Vascular Surgery ® aims to be the premier international journal of medical, endovascular and surgical care of vascular diseases. It is dedicated to the science and art of vascular surgery and aims to improve the management of patients with vascular diseases by publishing relevant papers that report important medical advances, test new hypotheses, and address current controversies. To acheive this goal, the Journal will publish original clinical and laboratory studies, and reports and papers that comment on the social, economic, ethical, legal, and political factors, which relate to these aims. As the official publication of The Society for Vascular Surgery, the Journal will publish, after peer review, selected papers presented at the annual meeting of this organization and affiliated vascular societies, as well as original articles from members and non-members.